Optogenetic stimulation of the dorsal striatum bidirectionally controls seizures
Open Access
- 31 March 2025
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (14)
Abstract
Despite a century of development of antiseizure medications, up to a third of people with epilepsy do not achieve seizure freedom with drug therapy. Deep brain stimulation is of growing use, but just as with pharmacotherapy, is not universally effective. Identifying new targets for deep brain stimulation—and in particular sites that are effective against a range of seizure types—may close this gap. Engagement of the basal ganglia experimental seizures was first observed almost 75 y ago. However, the role of the basal ganglia’s input nucleus, the striatum, in seizure control is relatively understudied. To address this gap, we used an optogenetic approach to activate and inactivate neurons in the dorsal striatum of rats submitted to the gamma-butyrolactone (GBL) model of absence epilepsy, amygdala kindling model of temporal lobe epilepsy, and pilocarpine-induced Status Epilepticus (SE). Open-loop (continuous light delivery) optogenetic activation of dorsal striatal neurons robustly suppressed seizures in all models. By contrast, open-loop optogenetic silencing increased absence seizure expression and facilitated SE onset but had no effect on kindled seizures. In the GBL model, we also tested the effects of closed-loop modulation (light delivery in response to seizure detection). Closed-loop activation reduced duration of spike-wave discharges (SWDs), while closed-loop inhibition increased SWD duration. These results demonstrated previously unrecognized antiabsence effects associated with striatal neuromodulation. These findings demonstrate a robust, bidirectional role of the dorsal striatum in the control of multiple seizure types, suggesting that the striatum is a site that can exert broad-spectrum control of seizures.Keywords
All Related Versions
Funding Information
- HHS | NIH | National Institute of Neurological Disorders and Stroke (R01NS097762)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (F30NS110318)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (T32NS041231)
This publication has 57 references indexed in Scilit:
- Mapping Lesion-Related Epilepsy to a Human Brain NetworkJAMA Neurology, 2023
- Topography of dyskinesias and torticollis evoked by inhibition of substantia nigra pars reticulataMovement Disorders, 2012
- Patterns of axonal branching of neurons of the substantia nigra pars reticulata and pars lateralis in the ratJournal of Comparative Neurology, 2005
- Comparison of the basal ganglia in rats, marmosets, macaques, baboons, and humans: Volume and neuronal number for the output, internal relay, and striatal modulating nucleiJournal of Comparative Neurology, 2002
- Interactions between limbic, thalamo-striatal-cortical, and central autonomic pathways during epileptic seizure progressionJournal of Comparative Neurology, 1999
- Alterations in GABAAReceptor α1 and α4 Subunit mRNA Levels in Thalamic Relay Nuclei Following Absence-like Seizures in RatsExperimental Neurology, 1998
- Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: A stereological study using the cavalieri and optical disector methodsJournal of Comparative Neurology, 1996
- Intrastriatal N-methyl-d-aspartate prevents amygdala kindled seizures in ratsBrain Research, 1986
- Effect of stimulation of the putamen on the substantia nigra in the catBrain Research, 1981
- Dissemination of Acute Focal Seizures In the MonkeyArchives of Neurology, 1965